Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of Arsenic Trioxide With Cyclophosphamide in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT03318016 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT03318016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03318016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of Arsenic Trioxide With Cyclophosphamide in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Lead sponsor
University of Colorado, Denver
Phase
Phase 1
Overall status
Terminated
Start date
December 15, 2017
Completion date
January 20, 2021
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, relapsed/refractory acute myeloid leukemia